- PyroGenesis (PYR) has received approval from the Toronto Stock Exchange to implement a Normal Course Issuer Bid
- PyroGenesis may purchase up to 7,500,000 common shares over a period of 12 months between February 15, 2022 and February 14, 2023
- The NCIB is expected to enhance value and liquidity for the company’s shareholders
- Shares purchased under the NCIB will be cancelled
- PyroGenesis Canada is a leader in the design, development, manufacture and commercialization of advanced plasma processes and sustainable solutions
- PyroGenesis Canada Inc. (PYR) opened trading at C$3.29 per share
PyroGenesis (PYR) has received approval from the Toronto Stock Exchange to implement a Normal Course Issuer Bid (NCIB).
PyroGenesis may purchase up to 7,500,000 common shares over a period of 12 months between February 15, 2022 and February 14, 2023.
As of February 7, 2022, there were 170,125,795 common shares of PyroGenesis issued and outstanding.
PyroGenesis may purchase up to 78,089 common shares per day.
All purchases made by the company will be through Pollitt & Co. Inc. The purchases will be made through the facilities of the TSX or alternative trading systems. The shares purchased under the NCIB will be cancelled.
The company believes that the proposed purchasing of its common shares will enhance value and liquidity for its shareholders.
Under the previous NCIB, which ended on January 13, 2022, 5,000,000 common shares were approved for purchase, of which 840,094 common shares were purchased. The weighted average price paid per common share purchased was $4.96.
PyroGenesis Canada is a leader in the design, development, manufacture and commercialization of advanced plasma processes and sustainable solutions.
PyroGenesis Canada Inc. (PYR) opened trading at C$3.29 per share.